2416P Prevalence, clonal dynamics and clinical impact of clonal hematopoiesis (CH) in patients (pts) receiving 177Lu-PSMA-617 (LuPSMA) for metastatic castration-resistant prostate cancer (mCRPC)
Year: 2025
Type: article
Source: Annals of Oncology
Authors: P. Ravi, C. Zhong, K. Perez, W. Xie, H.A. Stoltenberg, G-S.M. Lee, V. Volpe, L. Weeks, H. Jacene, A. Sperling
Institution: Dana-Farber Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4415941193